6th International
Cancer Study & Therapy Conference

April 29-30, 2020 - Orlando, USA

Important Dates

Interplay and cancer modulation Keynote Presentation Towards better understanding of pediatric cancer Targeted Multifunctional Hybrid Agents for Oncotheranostics

About Conference

6th International Cancer Study & Therapy Conference is going to be held during April 29-30, 2020 at Orlando, USA. Cancer Science-2020 is an initiative to unite the diverse researchers and business communities working in the field of cancer under one roof to understand the underlying biological procedures, current treatments which can be amended to increase effectiveness, precision, survivability and quality of life in cancer patients. Cancer is a leading cause of death worldwide. It is not a single disease to combat. Hence, there is a need for inter-disciplinary search globally: on how cancers develop, how to detect cancers at an early stage, how to design new anti-cancer therapies with greater efficiency, how to evaluate cancer risk and how to even prevent cancer from arising.

Read More..

Scientific Sessions

  • Radiation therapy, Chemo-therapy & Surgery in Cancer
  • Clinical Trials, Anti-cancer Drugs & Mechanism of Action
  • Immunotherapy, Stem Cell Therapy & Cancer Nursing
  • Targeted & Precision Medicine in Cancer
  • Pharmaceutical & Pharmacological Cancer Studies
  • Medicinal Plants & Nanotechnology in Cancer
Read More..

Committee Members

Padmanabhan P. Nair
NonInvasive Technologies LLC, USA
Shulamith Kreitler
Tel-Aviv University, Israel
Georgiev George Pavlovich
Institute of Gene Biology, Russia
George G Chen
The Chinese University of Hong Kong, China
Atif A. Ahmed
University of Missouri, USA
Sergey M. Deyev
Russian Academy of Sciences, Russia
Ramadasan Kuttan
Amala Cancer Research Centre, India
Alatangaole  Damirin
Inner Mongolia University, China
K. K. Janardhanan
Amala Cancer Research Centre, India
Guang-Yu Yang
Northwestern University, USA
Sample photo Sample photo Sample photo Sample photo Sample photo Sample photo Sample photo Sample photo

Why to Attend

Cancer Science-2020

Enables you to be known in academic circles to convene prearranged panels including delegates from companies and universities. This scientific meeting provides access to research activities related to a particular subject with current findings and developments anticipated from them.

Networking for Future Collaborations:

Participants will get engaged in learning latest research finding from the interesting presentations, workshops, poster presentations. These networking events will helps in making new connections which will aid your future collaborations.

Renowned Speakers:

Meet Renewed Speakers related to the conference and earn a priceless chance to sharpen your saw by learning new skills in a different environment.

Early Bird Registration

Academic

$699
  • Conference materials
  • Lunch and refreshments
  • Entry to the trade exhibition
  • Online access to abstracts

Delegate

$799
  • Conference materials
  • Lunch and refreshments
  • Entry to the trade exhibition
  • Online access to abstracts

Student

$300
  • Conference materials
  • Lunch and refreshments
  • Entry to the trade exhibition
  • Online access to abstracts

Media Partners

touchONCOLOGY
The Pharma Times
The medical tourism directory helps you find the best cancer hospitals and clinics in the world.
THE PHARMA WORLD
MEDPROINFO
CN1699

Mail us at

cancer@madridge.com
contact@madridge.com

Contact At

Whatsapp: whatsapplogo +91-8885537626

Contact Us

"I would like to thank you for the excellent organization of the conference. Thank you for your cooperation & waiting for your upcoming conferences."

- Maha Mohamed Adel Elgammal, Alexandria University, Egypt

"The conference was successfully organized by the organizers, thanks for providing us with a platform for academic exchange. We also sincerely thank you and other organizers for your concern and help during the conference."

- Alatangaole Damirin, Inner Mongolia University, China

"My congratulations for all your very useful clinical-scientific activities, awaiting for more collaboration in the future."

- Calogero Rinzivillo, University of Catania, Italy